ResearcherUniversity of UtahNo recent work listed
Gursimran Singh Kochhar
Matched on ORCID iD 0000-0002-0597-2760; OpenAlex author ID A5078399989. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2019: 1 paper · 2020: 1 paper · 2021: none · 2022: 1 paper
Papers 3
- Association of BRCA Mutations and Pancreatic Cancer: Review of Literature and Meta-analysis. Last author DOI 10.1097/mpa.0000000000001956↗
- Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Chemotherapy. Co-author DOI 10.1007/s12029-019-00303-z↗
- Defining Pancreatitis as a Risk Factor for Pancreatic Cancer: The Role, Incidence, and Timeline of Development. Co-author DOI 10.1097/mpa.0000000000001367↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Antonio Facciorusso · 1 shared paper, 2022 · strength 0.19
- Daryl Ramai · 1 shared paper, 2022 · strength 0.19
- Saurabh Chandan · 1 shared paper, 2022 · strength 0.19
- Shyam J Thakkar · 2 shared papers, 2019–2020 · strength 0.18
- Paper Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Che… DOI 10.1007/s12029-019-00303-z↗
- Paper Defining Pancreatitis as a Risk Factor for Pancreatic Cancer: The Role, Incidence, and Timeline of Development. DOI 10.1097/mpa.0000000000001367↗
- Aslam Syed · 2 shared papers, 2019–2020 · strength 0.18
- Paper Survival Trends for Resectable Pancreatic Cancer Using a Multidisciplinary Conference: the Impact of Post-operative Che… DOI 10.1007/s12029-019-00303-z↗
- Paper Defining Pancreatitis as a Risk Factor for Pancreatic Cancer: The Role, Incidence, and Timeline of Development. DOI 10.1097/mpa.0000000000001367↗
- Dulabh Kaur Monga · 1 shared paper, 2020 · strength 0.09
- Suzanne Schiffman · 1 shared paper, 2020 · strength 0.09
- Alexander V. Kirichenko · 1 shared paper, 2020 · strength 0.09
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.